How many other ASX bio stocks receive large amounts of royalty income (latest estimates are of approx $200 mill) from US giants such as Abbotts and J&J?
The recent dividend and buy back announcements reflect the luxurious position PTD is now in. It has guaranteed revenue until 2011 by which time some of its blue sky products will have an opportunity to prove themselves. A lot of other bio stocks won't even be trading in 5 years pal.....
